Inside Molecular: Conversations Across BD Molecular Diagnostics

BD Molecular Diagnostics
  • 0,0 (0)
  • Life Science
  • Varje månad

Inside Molecular: Conversations Across BD Molecular Diagnostics is a podcast series exploring the BD Molecular Diagnostics portfolio. From key clinically relevant assays to laboratory automation, the series offers practical insights into how BD Molecular Diagnostics continues to evolve and can support better decision‑making in healthcare. Disclaimer: Waters Corporation has acquired BD [Biosciences/Diagnostic Solutions]. BD remains the legal manufacturer until all required regulatory transfers are complete. Learn more: www.waters.com/bdtransaction

Avsnitt

  1. Extragenital CT/NG Testing at Scale

    15 juni

    Extragenital CT/NG Testing at Scale

    Learn how a large, multi-site study supports laboratory adoption of extragenital CT/NG testing on an automated, high throughput platform. This episode reviews importance of extragenital sample collection for STI testing, performance of extragenital STI testing on the BD COR™ System, and operational benefits of high-throughput automation. Disclaimer: Waters Corporation has acquired BD [Biosciences/Diagnostic Solutions]. BD remains the legal manufacturer until all required regulatory transfers are complete. Learn more: www.waters.com/bdtransaction

    25 min
  2. Extended Genotyping for HPV+: Clear, Convenient, Guideline-Supported

    18 maj

    Extended Genotyping for HPV+: Clear, Convenient, Guideline-Supported

    This episode explores the latest in HPV screening guidelines, how extended genotyping can give you more clinical insights and how to easily interpret extended genotyping results using the ASCCP App.1 The program will also highlight the option of guidelines‑supported self‑collection* in a healthcare setting, including its potential to expand access to HPV screening, along with practical considerations for clinical workflow.2-5 1. ASCCP Guidelines: Journal of Lower Genital Tract Disease ():10.1097, January 10, 2025.2. Wentzensen N, et al. J Low Genit Tract Dis. 2025;29(2):109‑126.3. ACS: Perkins RB, Wolf AMD, Church TR, et al. Self-collected vaginal specimens for human papillomavirus testing and guidance on screening exit: An update to the American Cancer Society cervical cancer screening guideline. CA Cancer J Clin. 2026;e70041. doi:10.3322/caac.700414. HRSA: Women’s Preventive Services Guidelines | HRSA accessed February 2026.5. ACOG: ACOG Statement issued January 5th, 2026.   *Self-collected vaginal specimens, obtained in a healthcare setting, can be tested as an alternative specimen type when cervical sampling is either contraindicated or cervical samples otherwise cannot be obtained. Disclaimer: The BD Biosciences and BD Diagnostic Solutions businesses have been acquired by Waters Corporation (“Waters”). Becton, Dickinson and Company or one of its affiliates or subsidiaries (“BD”) remains the legal manufacturer of Biosciences and Diagnostic Solutions products until all required regulatory transfers are completed. During this interim period, BD maintains full responsibility for all regulatory obligations of the legal manufacturer. Product information provided here is supplied under BD’s regulatory authority. To learn more about the relationship between Waters and BD during this transition period, please see our detailed summary: www.waters.com/bdtransaction

    22 min

  3. Trailer för säsong 1

    Introduction - Inside Molecular Trailer

    Welcome to Inside Molecular, a new podcast series exploring the BD Molecular Diagnostics portfolio—and the purpose and progress behind each solution.

    1 min

Trailer

Om

Inside Molecular: Conversations Across BD Molecular Diagnostics is a podcast series exploring the BD Molecular Diagnostics portfolio. From key clinically relevant assays to laboratory automation, the series offers practical insights into how BD Molecular Diagnostics continues to evolve and can support better decision‑making in healthcare. Disclaimer: Waters Corporation has acquired BD [Biosciences/Diagnostic Solutions]. BD remains the legal manufacturer until all required regulatory transfers are complete. Learn more: www.waters.com/bdtransaction

Information